Vardenafil (Levitra) for erectile dysfunction: a systematic review and meta-analysis of clinical trial reports - PubMed (original) (raw)
Meta-Analysis
Vardenafil (Levitra) for erectile dysfunction: a systematic review and meta-analysis of clinical trial reports
S Markou et al. Int J Impot Res. 2004 Dec.
Abstract
Trials of the efficacy and safety of vardenafil in the treatment of male erectile dysfunction (ED) were meta-analysed. All available databases were searched (January 1, 2001-November 30, 2003). Trials were eligible if they included men with ED, compared vardenafil with placebo, were randomized, were at least of 12 weeks duration, and assessed clinically relevant outcomes. Two reviewers independently evaluated study quality and extracted data in a standardized fashion. Nine trials (6809 men) met the inclusion criteria. In results pooled from seven fixed-dose trials, vardenafil increases the Erectile Function domain of the International Index of Erectile Function questionnaire by 6.18 units (weighted mean difference (WMD)). Vardenafil also increases the percentage of erections firm enough to allow vaginal penetration (WMD: 26) and the percentage of sexual attempts that were successful per participant (WMD: 29.8). The percentage of men agreeing with the statement that 'the treatment they have been taking over the past 4 weeks improved their erections', is also in favour of vardenafil (relative risk (RR): 3). These efficacy variables appeared greater at higher doses, although there are no significant differences between 10 and 20 mg dose. The same results were extracted for the two flexible 'as needed' dosing trials. Discontinuations are greater at the vardenafil groups compared to placebo (RR: 2.25). Specific adverse events with vardenafil included flushing, dyspepsia, headache, and rhinitis. Vardenafil was not significantly associated with serious cardiovascular events or death. Vardenafil, in all treatment regimens, shows to possess superior efficacy to placebo in the treatment of patients with erectile dysfunction. More data is needed on patients' subgroups.
Similar articles
- Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus.
Vardi M, Nini A. Vardi M, et al. Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD002187. doi: 10.1002/14651858.CD002187.pub3. Cochrane Database Syst Rev. 2007. PMID: 17253475 Free PMC article. - Sildenafil for male erectile dysfunction: a systematic review and meta-analysis.
Fink HA, Mac Donald R, Rutks IR, Nelson DB, Wilt TJ. Fink HA, et al. Arch Intern Med. 2002 Jun 24;162(12):1349-60. doi: 10.1001/archinte.162.12.1349. Arch Intern Med. 2002. PMID: 12076233 - Sertindole for schizophrenia.
Lewis R, Bagnall AM, Leitner M. Lewis R, et al. Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2. Cochrane Database Syst Rev. 2005. PMID: 16034864 Free PMC article. - Psychosocial interventions for erectile dysfunction.
Melnik T, Soares BG, Nasselo AG. Melnik T, et al. Cochrane Database Syst Rev. 2007 Jul 18;2007(3):CD004825. doi: 10.1002/14651858.CD004825.pub2. Cochrane Database Syst Rev. 2007. PMID: 17636774 Free PMC article. - Vardenafil: a review of its use in erectile dysfunction.
Keating GM, Scott LJ. Keating GM, et al. Drugs. 2003;63(23):2673-703. doi: 10.2165/00003495-200363230-00010. Drugs. 2003. PMID: 14636086 Review.
Cited by
- Clinical Practice Guidelines for Management of Sexual Dysfunction.
Avasthi A, Grover S, Sathyanarayana Rao TS. Avasthi A, et al. Indian J Psychiatry. 2017 Jan;59(Suppl 1):S91-S115. doi: 10.4103/0019-5545.196977. Indian J Psychiatry. 2017. PMID: 28216788 Free PMC article. No abstract available. - Phosphodiesterase-5 inhibitors for erectile dysfunction in patients with diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials.
Balhara YP, Sarkar S, Gupta R. Balhara YP, et al. Indian J Endocrinol Metab. 2015 Jul-Aug;19(4):451-61. doi: 10.4103/2230-8210.159023. Indian J Endocrinol Metab. 2015. PMID: 26180759 Free PMC article. Review. - Randomized Trial of CPAP and Vardenafil on Erectile and Arterial Function in Men With Obstructive Sleep Apnea and Erectile Dysfunction.
Melehan KL, Hoyos CM, Hamilton GS, Wong KK, Yee BJ, McLachlan RI, O'Meagher S, Celermajer D, Ng MK, Grunstein RR, Liu PY. Melehan KL, et al. J Clin Endocrinol Metab. 2018 Apr 1;103(4):1601-1611. doi: 10.1210/jc.2017-02389. J Clin Endocrinol Metab. 2018. PMID: 29409064 Free PMC article. Clinical Trial. - Treatment options for sexual dysfunction in patients with chronic kidney disease: a systematic review of randomized controlled trials.
Vecchio M, Navaneethan SD, Johnson DW, Lucisano G, Graziano G, Querques M, Saglimbene V, Ruospo M, Bonifati C, Jannini EA, Strippoli GF. Vecchio M, et al. Clin J Am Soc Nephrol. 2010 Jun;5(6):985-95. doi: 10.2215/CJN.09081209. Epub 2010 May 24. Clin J Am Soc Nephrol. 2010. PMID: 20498250 Free PMC article. - COEXISTENCE, EXCLUSION, OR NEUTRALITY? A META-ANALYSIS OF COMPETITION BETWEEN AEDES ALBOPICTUS AND RESIDENT MOSQUITOES.
Juliano SA. Juliano SA. Isr J Ecol Evol. 2010 Jun 1;56(3-4):325-351. doi: 10.1560/IJEE.55.3-4.325. Epub 2011 Nov 21. Isr J Ecol Evol. 2010. PMID: 23482823 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous